DANIEL JOSEPH JANDREAU O.D.
Prescription History 1649338708
Optometrist in Caribou, ME

Active since December 04, 2006PECOS EnrolledAccepts Medicare Assignment
43 HATCH DR, SUITE 150, CARIBOU, ME 04736(207) 498-2538(207) 498-2539 Get Directions

NPPES record last updated: May 27, 2015. Verified against the NPPES registry weekly; last sync: October 11, 2026.

Medicare Part D Prescription History

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DANIEL JOSEPH JANDREAU O.D., an active Optometrist specialist practicing in Caribou, ME. Our medical registry currently tracks 6 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 140 documented patient claims. Among these therapy options, the most frequently utilized medication is Latanoprost, which accounts for 39 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.

6
Medications
140
Total Claims
313
30-Day Fills
Latanoprost
Most Prescribed · 39 claims
View details
6 medications · 2024 Medicare Part D
Medicare Part D medications prescribed by DANIEL JOSEPH JANDREAU O.D. in 2024, with prescription volumes, average cost per fill, and ME state comparisons
Medication Prescriptions (2024)Rx (2024) Avg Cost per FillCost / Fill Vs. Other ME PrescribersVs. ME Avg

About Latanoprost: Latanoprost is used to treat high pressure inside the eye due to glaucoma (open angle type) or other eye diseases (such as ocular hypertension). Show more ▾

It is similar to a natural chemical in the body (prostaglandin) and works by regulating the flow of fluid within the eye which results in lower pressure. Lowering high pressure inside the eye helps to prevent blindness. A prostaglandin F analog used to treat OCULAR HYPERTENSION in patients with GLAUCOMA.

In 2024, this provider wrote 39 Medicare prescriptions for Latanoprost, about a third of the volume of the typical Maine prescriber of this medication (104.7). Medicare paid an average of $20.80 per fill, versus $14.15 statewide.

How often this provider prescribes it

This provider
39
ME average
104.7

This provider prescribes this medication less often than the average ME prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$20.80
ME average
$14.15

Gross Part D cost per fill; not the patient's out-of-pocket price.

94.3
30-Day Fills
standardized to 30-day supplies
2,820
Days of Medication
total across all patients in 2024

About Lumigan: Bimatoprost is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾

Lowering high pressure inside the eye can help prevent blindness. This medication works by regulating the flow of fluid within the eye to maintain a normal pressure. A cloprostenol-derived amide that is used as an ANTIHYPERTENSIVE AGENT in the treatment of OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION.

In 2024, this provider wrote 35 Medicare prescriptions for Lumigan, about 76% of the volume of the typical Maine prescriber of this medication (45.9). Medicare paid an average of $547.70 per fill, versus $569.21 statewide.

How often this provider prescribes it

This provider
35
ME average
45.9

This provider's prescribing volume for this medication is in line with the average ME prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$547.70
ME average
$569.21

This provider's average cost per fill is below the ME average for this medication.

78.7
30-Day Fills
standardized to 30-day supplies
2,329
Days of Medication
total across all patients in 2024

About Timolol Maleate: This medication is used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾

Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers. A beta-adrenergic antagonist that is similar in action to PROPRANOLOL; the levo-isomer is more active. Timolol has been proposed as an anti-hypertensive, anti-arrhythmic, anti-angina, and anti-glaucoma agent. It is also used in the treatment of MIGRAINE DISORDERS and tremor.

In 2024, this provider wrote 28 Medicare prescriptions for Timolol Maleate, about half the volume of the typical Maine prescriber of this medication (56.4). Medicare paid an average of $31.41 per fill, versus $18.38 statewide.

How often this provider prescribes it

This provider
28
ME average
56.4

This provider prescribes this medication less often than the average ME prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$31.41
ME average
$18.38

Gross Part D cost per fill; not the patient's out-of-pocket price.

82.3
30-Day Fills
standardized to 30-day supplies
2,462
Days of Medication
total across all patients in 2024

About Neomycin-Polymyxin-Dexameth: This medication is used to treat conditions involving swelling (inflammation) of the eyes and to treat or prevent bacterial eye infections. Show more ▾

This product contains neomycin and polymyxin, antibiotics that work by stopping the growth of bacteria. It also contains dexamethasone, an anti-inflammatory corticosteroid that works by reducing swelling. This medication treats/prevents only bacterial eye infections. It will not work for other types of eye infections and may worsen them (such as infections caused by viruses, fungi, mycobacteria). Unnecessary use or overuse of any antibiotic can lead to its decreased effectiveness.

In 2024, this provider wrote 14 Medicare prescriptions for Neomycin-Polymyxin-Dexameth, about a third of the volume of the typical Maine prescriber of this medication (48.7). Medicare paid an average of $8.09 per fill, versus $9.91 statewide.

How often this provider prescribes it

This provider
14
ME average
48.7

This provider prescribes this medication less often than the average ME prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$8.09
ME average
$9.91

This provider's average cost per fill is below the ME average for this medication.

14
30-Day Fills
standardized to 30-day supplies
200
Days of Medication
total across all patients in 2024

About Alrex: This medication is used to temporarily relieve seasonal allergy symptoms of the eyes such as swelling, redness, and itching. Show more ▾

Loteprednol belongs to a class of drugs known as corticosteroids. An androstadiene derivative corticosteroid that is used as an ANTI-ALLERGIC AGENT for the treatment of inflammatory and allergic eye conditions.

In 2024, this provider wrote 12 Medicare prescriptions for Alrex. Medicare paid an average of $370.25 per fill. No state comparison is available for this medication.

How often this provider prescribes it

No state benchmark is available for this medication.

What Medicare paid per fill

$370.25
Cost per fill

Gross Part D cost per fill; not the patient's out-of-pocket price.

16.2
30-Day Fills
standardized to 30-day supplies
387
Days of Medication
total across all patients in 2024

About Combigan: This combination medication is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾

Lowering high pressure inside the eye helps to prevent blindness. This product contains brimonidine and timolol. These medications are used together when 1 drug is not controlling the pressure inside the eye. Brimonidine works by allowing better fluid drainage from within the eye and also by decreasing the amount of fluid formed in the eye. It belongs to a class of drugs known as alpha agonists. Timolol is thought to work by decreasing the amount of fluid formed in the eye. Timolol belongs to a class of drugs known as beta blockers. This medication is not recommended for use in children less than 2 years old due to an increased risk of serious side effects. Ask the doctor or pharmacist for more details. A pharmaceutical preparation of brimonidine tartrate and timolol maleate. The combined ADRENERGIC ALPHA2 RECEPTOR AGONIST and ADRENERGIC BETA-ANTAGONIST activity of these drugs reduce INTRAOCULAR PRESSURE in GLAUCOMA patients.

In 2024, this provider wrote 12 Medicare prescriptions for Combigan, about half the volume of the typical Maine prescriber of this medication (25.8). Medicare paid an average of $258.47 per fill, versus $405.48 statewide.

How often this provider prescribes it

This provider
12
ME average
25.8

This provider prescribes this medication less often than the average ME prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$258.47
ME average
$405.48

This provider's average cost per fill is below the ME average for this medication.

27
30-Day Fills
standardized to 30-day supplies
810
Days of Medication
total across all patients in 2024
No medications match the current filters.
▲ More than typical≈ Typical▼ Less than typical= prescription volume vs the average ME prescriber of the same medication; volume reflects practice size as well as clinical preference.Green cost= below the ME average cost per fill.

About this data. The prescription history for DANIEL JOSEPH JANDREAU O.D. is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Optometrist prescribing approach at this Caribou, ME practice.

Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among ME prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.

About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.